A team of scientists from the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, and Nanyang Technological University, Singapore (NTU Singapore) has developed a quick test kit that can tell if a person has immunity against Covid-19 and its variants, based on the antibodies detected in a blood sample. Unlike ART test kits — which look for the presence of viral proteins produced during a Covid-19 infection to determine if a person is infected — this rapid point-of-care test kit is a serology test that measures antibodies…
